| scholarly article | Q13442814 |
| P2093 | author name string | Bo Liu | |
| Jie Liu | |||
| Yi Chen | |||
| Jin Zhang | |||
| Rong-Rong He | |||
| Honggang Xiang | |||
| P2860 | cites work | Sirtuins in Renal Health and Disease | Q94073889 |
| Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity | Q22010164 | ||
| Acetylation-dependent regulation of Skp2 function | Q24292805 | ||
| SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress | Q24313709 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70 | Q24645120 | ||
| The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase | Q24671306 | ||
| Sirtuin 1 and sirtuin 3: physiological modulators of metabolism | Q26828607 | ||
| SIRT3 regulates progression and development of diseases of aging | Q26864656 | ||
| Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism | Q27679007 | ||
| Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3 | Q27684389 | ||
| Crystal structures of Sirt3 complexes with 4'-bromo-resveratrol reveal binding sites and inhibition mechanism | Q27687467 | ||
| On the Origin of Cancer Cells | Q27861025 | ||
| Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease | Q28068499 | ||
| Fighting neurodegeneration with rapamycin: mechanistic insights | Q28243647 | ||
| Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex | Q28249855 | ||
| SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth | Q28258574 | ||
| Conserved metabolic regulatory functions of sirtuins | Q28267340 | ||
| Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway | Q28468627 | ||
| Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3 | Q28512747 | ||
| SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model | Q28817614 | ||
| Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction | Q29619949 | ||
| A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis | Q29620243 | ||
| Docking and binding free energy calculations of sirtuin inhibitors | Q30316719 | ||
| Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway | Q30419038 | ||
| A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells | Q33636551 | ||
| Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway | Q33661644 | ||
| Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling | Q34024056 | ||
| SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome | Q34209480 | ||
| The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling | Q34556111 | ||
| Old enzymes, new tricks: sirtuins are NAD(+)-dependent de-acylases | Q41953666 | ||
| Correction for Papa and Germain, "SirT3 Regulates a Novel Arm of the Mitochondrial Unfolded Protein Response". | Q41954145 | ||
| SIRT3 Directs Carbon Traffic in Muscle to Promote Glucose Control | Q41980114 | ||
| SIRT3 reverses aging-associated degeneration | Q42029936 | ||
| Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice. | Q42202731 | ||
| Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway | Q42373717 | ||
| Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization. | Q42792585 | ||
| Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy | Q42872858 | ||
| Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly | Q44633411 | ||
| Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway | Q46238115 | ||
| Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor | Q46254405 | ||
| SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease | Q46262918 | ||
| Pyrroloquinoline quinone increases the expression and activity of Sirt1 and -3 genes in HepG2 cells | Q46267074 | ||
| SIRT3 protects hepatocytes from oxidative injury by enhancing ROS scavenging and mitochondrial integrity | Q46274273 | ||
| Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction | Q46303141 | ||
| Melatonin-mediated upregulation of Sirt3 attenuates sodium fluoride-induced hepatotoxicity by activating the MT1-PI3K/AKT-PGC-1α signaling pathway | Q46306810 | ||
| Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions? | Q46372529 | ||
| Sirt3 Deficiency Increased the Vulnerability of Pancreatic Beta Cells to Oxidative Stress-Induced Dysfunction | Q46390320 | ||
| Salidroside attenuates endothelial cellular senescence via decreasing the expression of inflammatory cytokines and increasing the expression of SIRT3. | Q47230286 | ||
| 2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells | Q47257443 | ||
| Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3. | Q47389936 | ||
| Human sirtuin 3 (SIRT3) deacetylates histone H3 lysine 56 to promote nonhomologous end joining repair | Q47404584 | ||
| MicroRNA-210 Modulates the Cellular Energy Metabolism Shift During H2O2-Induced Oxidative Stress by Repressing ISCU in H9c2 Cardiomyocytes | Q47651944 | ||
| miR-195 Regulates Metabolism in Failing Myocardium via Alterations in SIRT3 Expression and Mitochondrial Protein Acetylation. | Q47657886 | ||
| Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale. | Q47686470 | ||
| Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis | Q48148630 | ||
| Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress | Q48233603 | ||
| SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer. | Q48365119 | ||
| LncRNA TUG1 sponges miR-145 to promote cancer progression and regulate glutamine metabolism via Sirt3/GDH axis | Q48523033 | ||
| A small molecule activator of SIRT3 promotes deacetylation and activation of manganese superoxide dismutase | Q48720966 | ||
| Building and decoding ubiquitin chains for mitophagy | Q49864965 | ||
| Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity. | Q49999953 | ||
| Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy | Q50126710 | ||
| NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy. | Q51246484 | ||
| Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring Nε-thioacetyl-lysine. | Q51427110 | ||
| SIRT3 deficiency impairs mitochondrial and contractile function in the heart. | Q51632304 | ||
| Daily melatonin protects the endothelial lineage and functional integrity against the aging process, oxidative stress and toxic environment and restores blood flow in critical limb ischemia area in mice. | Q51760185 | ||
| SIRT3 deficiency exacerbates p53/Parkin‑mediated mitophagy inhibition and promotes mitochondrial dysfunction: Implication for aged hearts. | Q51763649 | ||
| Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson's Disease Treatment. | Q52347992 | ||
| NAD+-dependent deacetylase SIRT3 in adipocytes is dispensable for maintaining normal adipose tissue mitochondrial function and whole-body metabolism. | Q52596649 | ||
| SIRT3 restricts HBV transcription and replication via epigenetic regulation of cccDNA involving SUV39H1 and SETD1A histone methyltransferases. | Q52602564 | ||
| Parkinson's disease | Q54072241 | ||
| SIRT3 Protects Rotenone-induced Injury in SH-SY5Y Cells by Promoting Autophagy through the LKB1-AMPK-mTOR Pathway. | Q55315757 | ||
| NNMT activation can contribute to the development of fatty liver disease by modulating the NAD + metabolism. | Q55395460 | ||
| SIRT3 activator honokiol ameliorates surgery/anesthesia-induced cognitive decline in mice through anti-oxidative stress and anti-inflammatory in hippocampus | Q57192027 | ||
| Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis | Q58115601 | ||
| DNA-Encoded Dynamic Chemical Library and Its Applications in Ligand Discovery | Q58565356 | ||
| Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-α upregulation | Q58592592 | ||
| Mitochondria as a therapeutic target for common pathologies | Q58611546 | ||
| Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition | Q58764473 | ||
| SIRT3 Activation by Dihydromyricetin Suppresses Chondrocytes Degeneration via Maintaining Mitochondrial Homeostasis | Q59132734 | ||
| Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis suppression of sirtuin 3 in pancreatic cancer | Q59328828 | ||
| Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis | Q34598059 | ||
| SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization | Q34729713 | ||
| 4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification. | Q35041432 | ||
| Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury | Q35056744 | ||
| SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production | Q35100923 | ||
| SnapShot: Mammalian Sirtuins. | Q35111981 | ||
| Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production | Q35197888 | ||
| Mechanism of inhibition of the human sirtuin enzyme SIRT3 by nicotinamide: computational and experimental studies | Q35252505 | ||
| Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells | Q35568870 | ||
| Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD | Q35573153 | ||
| Energy metabolism in heart failure | Q35602060 | ||
| Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3 | Q35636476 | ||
| SIRT3 Is Crucial for Maintaining Skeletal Muscle Insulin Action and Protects Against Severe Insulin Resistance in High-Fat-Fed Mice | Q35973881 | ||
| High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss | Q35995078 | ||
| NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. | Q36038362 | ||
| trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease | Q36098005 | ||
| Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation | Q36099753 | ||
| SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin | Q36111628 | ||
| Analysis of acetylation stoichiometry suggests that SIRT3 repairs nonenzymatic acetylation lesions | Q36270948 | ||
| Sirtuin Inhibition: Strategies, Inhibitors, and Therapeutic Potential | Q36340474 | ||
| Are sirtuins viable targets for improving healthspan and lifespan? | Q36385747 | ||
| The Emerging Hallmarks of Cancer Metabolism | Q36468964 | ||
| Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies | Q36573949 | ||
| LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2α/Notch3 pathways | Q36574347 | ||
| SIRT3 Blocks Aging-Associated Tissue Fibrosis in Mice by Deacetylating and Activating Glycogen Synthase Kinase 3β. | Q36597265 | ||
| Loss of Fatty Acid Binding Protein 4/aP2 Reduces Macrophage Inflammation Through Activation of SIRT3 | Q36632410 | ||
| Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1β axis in mice | Q36634376 | ||
| SIRT3 Deficiency Induces Endothelial Insulin Resistance and Blunts Endothelial-Dependent Vasorelaxation in Mice and Human with Obesity | Q36713609 | ||
| Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology | Q36728778 | ||
| Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma | Q36809567 | ||
| SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression | Q36868674 | ||
| Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface | Q36887547 | ||
| Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation | Q37193340 | ||
| Inhibition of ROS and upregulation of inflammatory cytokines by FoxO3a promotes survival against Salmonella typhimurium | Q37257178 | ||
| SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2 | Q37296133 | ||
| Melatonin improves age-induced fertility decline and attenuates ovarian mitochondrial oxidative stress in mice | Q37330537 | ||
| Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. | Q37343700 | ||
| Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer | Q37620630 | ||
| Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity | Q37695433 | ||
| Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors | Q37727564 | ||
| Activation of Sirtuin 3 by Silybin Attenuates Mitochondrial Dysfunction in Cisplatin-induced Acute Kidney Injury | Q37737807 | ||
| The SirT3 divining rod points to oxidative stress | Q37887129 | ||
| The Role of p53 in Metabolic Regulation | Q37903700 | ||
| Sirtuins mediate mammalian metabolic responses to nutrient availability | Q37976307 | ||
| Metabolic regulation by SIRT3: implications for tumorigenesis | Q38022918 | ||
| Mitochondrial cytopathies and cardiovascular disease | Q38180688 | ||
| SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection | Q38665115 | ||
| SIRT3 Enhances Mesenchymal Stem Cell Longevity and Differentiation. | Q38674686 | ||
| Melatonin protects against maternal obesity-associated oxidative stress and meiotic defects in oocytes via the SIRT3-SOD2-dependent pathway. | Q38704383 | ||
| The expression of SIRT3 in primary hepatocellular carcinoma and the mechanism of its tumor suppressing effects | Q38710818 | ||
| A small-molecule activator induces ULK1-modulating autophagy-associated cell death in triple negative breast cancer | Q38760946 | ||
| Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity | Q38822588 | ||
| Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway | Q38881949 | ||
| NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo | Q38927795 | ||
| Sirtuin 3: A Janus face in cancer (Review). | Q39007460 | ||
| Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex | Q39028348 | ||
| Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress. | Q39123771 | ||
| Sirt3 is a tumor suppressor in lung adenocarcinoma cells | Q39127721 | ||
| MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Q39139786 | ||
| Mitochondrial Sirtuins and Molecular Mechanisms of Aging. | Q39174949 | ||
| Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2. | Q39307719 | ||
| Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles | Q39321120 | ||
| SIRT3: Oncogene and Tumor Suppressor in Cancer. | Q39433144 | ||
| SIRT3 attenuates AngII-induced cardiac fibrosis by inhibiting myofibroblasts transdifferentiation via STAT3-NFATc2 pathway | Q41364227 | ||
| Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis | Q41628391 | ||
| Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | Q41636426 | ||
| Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway | Q41665102 | ||
| FOXO3A directs a protective autophagy program in haematopoietic stem cells. | Q41894710 | ||
| Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. | Q41913346 | ||
| Sirtuin 3 deficiency aggravates contrast-induced acute kidney injury | Q59336990 | ||
| The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer | Q60044742 | ||
| Sirt3 suppresses calcium oxalate-induced renal tubular epithelial cell injury via modification of FoxO3a-mediated autophagy | Q61816619 | ||
| SIRT3-Dependent Mitochondrial Dynamics Remodeling Contributes to Oxidative Stress-Induced Melanocyte Degeneration in Vitiligo | Q64093305 | ||
| SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair | Q64115640 | ||
| SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism | Q64266460 | ||
| SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy | Q64277468 | ||
| Therapeutic approaches to Huntington disease: from the bench to the clinic | Q64859904 | ||
| miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3 | Q64920897 | ||
| Color-Mediated Contrast Sensitivity in Disabled Readers | Q67916777 | ||
| Alzheimer's disease | Q79264357 | ||
| Human SIRT3 tripeptidic inhibitors containing N(ε)-thioacetyl-lysine | Q85666749 | ||
| An inhibitor of oxidative phosphorylation exploits cancer vulnerability | Q89070252 | ||
| Suppression of Endothelial-to-Mesenchymal Transition by SIRT (Sirtuin) 3 Alleviated the Development of Hypertensive Renal Injury | Q89143412 | ||
| Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3 | Q89143446 | ||
| MicroRNA-421 induces hepatic mitochondrial dysfunction in non-alcoholic fatty liver disease mice by inhibiting sirtuin 3 | Q89285073 | ||
| SIRT3 Inactivation Promotes Acute Kidney Injury Through Elevated Acetylation of SOD2 and p53 | Q90014679 | ||
| SIRT2: Controversy and multiple roles in disease and physiology | Q90035223 | ||
| SIRT3 inhibited the formation of calcium oxalate-induced kidney stones through regulating NRF2/HO-1 signaling pathway | Q90479829 | ||
| Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy | Q90591742 | ||
| Celastrol protects human retinal pigment epithelial cells against hydrogen peroxide mediated oxidative stress, autophagy, and apoptosis through sirtuin 3 signal pathway | Q90933575 | ||
| Biological Functions of Autophagy Genes: A Disease Perspective | Q91003224 | ||
| SIRT3 promotes the invasion and metastasis of cervical cancer cells by regulating fatty acid synthase | Q91063764 | ||
| Protective effects of polydatin against sulfur mustard-induced hepatic injury | Q91199036 | ||
| MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3 | Q91227731 | ||
| Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells | Q91272499 | ||
| Sirt3 Deficiency Shortens Life Span and Impairs Cardiac Mitochondrial Function Rescued by Opa1 Gene Transfer | Q91589126 | ||
| A novel metadherinΔ7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFĸB-SIRT3 axis | Q91736468 | ||
| Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia | Q91744014 | ||
| MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial activity and increase oxidative stress in oral carcinoma | Q91760955 | ||
| 4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming | Q91778758 | ||
| SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism | Q91851871 | ||
| SIRT5 impairs aggregation and activation of the signaling adaptor MAVS through catalyzing lysine desuccinylation | Q92010137 | ||
| Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells | Q92048358 | ||
| Mitochondrial NOS1 suppresses apoptosis in colon cancer cells through increasing SIRT3 activity | Q92461921 | ||
| LncRNA DYNLRB2-2 inhibits THP-1 macrophage foam cell formation by enhancing autophagy | Q92569158 | ||
| Sirt3 modulate renal ischemia-reperfusion injury through enhancing mitochondrial fusion and activating the ERK-OPA1 signaling pathway | Q92583059 | ||
| Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κBTGF-β1/Smad Signaling Pathway | Q92634138 | ||
| Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis | Q92658293 | ||
| Inhibition of Mitochondrial Oxidative Damage Improves Reendothelialization Capacity of Endothelial Progenitor Cells via SIRT3 (Sirtuin 3)-Enhanced SOD2 (Superoxide Dismutase 2) Deacetylation in Hypertension | Q92687993 | ||
| Impaired SIRT3 activity mediates cardiac dysfunction in endotoxemia by calpain-dependent disruption of ATP synthesis | Q92764730 | ||
| Context-Dependent Roles for SIRT2 and SIRT3 in Tumor Development Upon Calorie Restriction or High Fat Diet | Q92862803 | ||
| SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation | Q93006989 | ||
| Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia | Q93017932 | ||
| Hepatic SIRT3 Upregulation in Response to Chronic Alcohol Consumption Contributes to Alcoholic Liver Disease in Mice | Q93047072 | ||
| ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation | Q93076729 | ||
| Dexmedetomidine attenuation of renal ischaemia-reperfusion injury requires sirtuin 3 activation | Q93156536 | ||
| IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies | Q93222571 | ||
| P433 | issue | 18 | |
| P304 | page(s) | 8315-8342 | |
| P577 | publication date | 2020-07-09 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target | |
| P478 | volume | 10 |
Search more.